Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling
<b>Background/Objectives</b>: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is commonly considered as a hepatic manifestation of metabolic syndrome, posing considerable public health and economic challenges due to its high prevalence. This study investigates the diagno...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/2/425 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850080563748143104 |
|---|---|
| author | Ting Zeng Fang Li Min Yang Yao Wu Wei Cui Huaming Mou Xiaohe Luo |
| author_facet | Ting Zeng Fang Li Min Yang Yao Wu Wei Cui Huaming Mou Xiaohe Luo |
| author_sort | Ting Zeng |
| collection | DOAJ |
| description | <b>Background/Objectives</b>: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is commonly considered as a hepatic manifestation of metabolic syndrome, posing considerable public health and economic challenges due to its high prevalence. This study investigates the diagnostic potential of serum galectin-1 levels in MASLD patients. <b>Methods</b>: A total of 128 participants were analyzed for this study, comprising 68 healthy controls and 60 MASLD patients. The hepatic steatosis index (HSI) and fatty liver index (FLI) were calculated to evaluate the liver steatosis. Serum galectin-1 levels were measured using an enzyme-linked immunosorbent assay. We additionally conducted a comparative analysis of galectin-1 mRNA and protein expression levels in the liver tissue between the mouse models of MASLD, including ob/ob mice (<i>n</i> = 6), high-fat diet-fed C57 mice (<i>n</i> = 6), and the control group (<i>n</i> = 6). <b>Results</b>: Average serum galectin-1 levels significantly differed between groups, with lower values in the controls (<i>p</i> < 0.01). The frequency of MASLD increased with higher quartiles of galectin-1 levels (<i>p</i> < 0.01). The correlation analysis showed a positive relationship between serum galectin-1 and both HSI and FLI (<i>p</i> < 0.01). The multivariate logistic regression indicated that elevated galectin-1 was associated with an increased risk of MASLD (<i>p</i> < 0.01), yielding an area under the receiver operating characteristic curve for predicting MASLD at 0.745 (95% CI: 0.662–0.829). Hepatic galectin-1 levels were also elevated in the MASLD mouse model at both transcript and protein levels (<i>p</i> < 0.01). <b>Conclusions</b>: Serum galectin-1 can be used as a potential biomarker to help diagnose MASLD. |
| format | Article |
| id | doaj-art-c621f623459b403d879be2fcf5240757 |
| institution | DOAJ |
| issn | 2227-9059 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj-art-c621f623459b403d879be2fcf52407572025-08-20T02:44:55ZengMDPI AGBiomedicines2227-90592025-02-0113242510.3390/biomedicines13020425Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience SamplingTing Zeng0Fang Li1Min Yang2Yao Wu3Wei Cui4Huaming Mou5Xiaohe Luo6Department of Laboratory Medicine, Chongqing University Three Gorges Hospital, School of Medicine, Chongqing University, Chongqing 404000, ChinaDepartment of Laboratory Medicine, Chongqing University Three Gorges Hospital, School of Medicine, Chongqing University, Chongqing 404000, ChinaDepartment of Laboratory Medicine, Chongqing University Three Gorges Hospital, School of Medicine, Chongqing University, Chongqing 404000, ChinaDepartment of Laboratory Medicine, Chongqing University Three Gorges Hospital, School of Medicine, Chongqing University, Chongqing 404000, ChinaThe Center of Clinical Research of Endocrinology and Metabolic Diseases in Chongqing, Chongqing University Three Gorges Hospital, School of Medicine, Chongqing University, Chongqing 404000, ChinaDepartment of Cardiovascular Medicine, Chongqing University Three Gorges Hospital, School of Medicine, Chongqing University, Chongqing 404000, ChinaDepartment of Laboratory Medicine, Chongqing University Three Gorges Hospital, School of Medicine, Chongqing University, Chongqing 404000, China<b>Background/Objectives</b>: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is commonly considered as a hepatic manifestation of metabolic syndrome, posing considerable public health and economic challenges due to its high prevalence. This study investigates the diagnostic potential of serum galectin-1 levels in MASLD patients. <b>Methods</b>: A total of 128 participants were analyzed for this study, comprising 68 healthy controls and 60 MASLD patients. The hepatic steatosis index (HSI) and fatty liver index (FLI) were calculated to evaluate the liver steatosis. Serum galectin-1 levels were measured using an enzyme-linked immunosorbent assay. We additionally conducted a comparative analysis of galectin-1 mRNA and protein expression levels in the liver tissue between the mouse models of MASLD, including ob/ob mice (<i>n</i> = 6), high-fat diet-fed C57 mice (<i>n</i> = 6), and the control group (<i>n</i> = 6). <b>Results</b>: Average serum galectin-1 levels significantly differed between groups, with lower values in the controls (<i>p</i> < 0.01). The frequency of MASLD increased with higher quartiles of galectin-1 levels (<i>p</i> < 0.01). The correlation analysis showed a positive relationship between serum galectin-1 and both HSI and FLI (<i>p</i> < 0.01). The multivariate logistic regression indicated that elevated galectin-1 was associated with an increased risk of MASLD (<i>p</i> < 0.01), yielding an area under the receiver operating characteristic curve for predicting MASLD at 0.745 (95% CI: 0.662–0.829). Hepatic galectin-1 levels were also elevated in the MASLD mouse model at both transcript and protein levels (<i>p</i> < 0.01). <b>Conclusions</b>: Serum galectin-1 can be used as a potential biomarker to help diagnose MASLD.https://www.mdpi.com/2227-9059/13/2/425metabolic dysfunction-associated steatotic liver diseaseserum galectin-1 levelsdiagnostic markerfatty liver indexhepatic steatosis index |
| spellingShingle | Ting Zeng Fang Li Min Yang Yao Wu Wei Cui Huaming Mou Xiaohe Luo Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling Biomedicines metabolic dysfunction-associated steatotic liver disease serum galectin-1 levels diagnostic marker fatty liver index hepatic steatosis index |
| title | Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling |
| title_full | Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling |
| title_fullStr | Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling |
| title_full_unstemmed | Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling |
| title_short | Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling |
| title_sort | feasibility of serum galectin 1 as a diagnostic biomarker for metabolic dysfunction associated steatotic liver disease a study on a segment of the chinese population using convenience sampling |
| topic | metabolic dysfunction-associated steatotic liver disease serum galectin-1 levels diagnostic marker fatty liver index hepatic steatosis index |
| url | https://www.mdpi.com/2227-9059/13/2/425 |
| work_keys_str_mv | AT tingzeng feasibilityofserumgalectin1asadiagnosticbiomarkerformetabolicdysfunctionassociatedsteatoticliverdiseaseastudyonasegmentofthechinesepopulationusingconveniencesampling AT fangli feasibilityofserumgalectin1asadiagnosticbiomarkerformetabolicdysfunctionassociatedsteatoticliverdiseaseastudyonasegmentofthechinesepopulationusingconveniencesampling AT minyang feasibilityofserumgalectin1asadiagnosticbiomarkerformetabolicdysfunctionassociatedsteatoticliverdiseaseastudyonasegmentofthechinesepopulationusingconveniencesampling AT yaowu feasibilityofserumgalectin1asadiagnosticbiomarkerformetabolicdysfunctionassociatedsteatoticliverdiseaseastudyonasegmentofthechinesepopulationusingconveniencesampling AT weicui feasibilityofserumgalectin1asadiagnosticbiomarkerformetabolicdysfunctionassociatedsteatoticliverdiseaseastudyonasegmentofthechinesepopulationusingconveniencesampling AT huamingmou feasibilityofserumgalectin1asadiagnosticbiomarkerformetabolicdysfunctionassociatedsteatoticliverdiseaseastudyonasegmentofthechinesepopulationusingconveniencesampling AT xiaoheluo feasibilityofserumgalectin1asadiagnosticbiomarkerformetabolicdysfunctionassociatedsteatoticliverdiseaseastudyonasegmentofthechinesepopulationusingconveniencesampling |